Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-557

@Davisite

nothing to do again this weekend.

A little perspective please. BITs enterprise value is around $100M. lol. what would you like it to be $5M.
You are definately sounding more bitter lately for someone that was only interested by the scIence.

Are there many drugs that will combat both HIV and HCV at once, I definitely see an opportunity in this space, especially in Asia.

For some reason you don't feel Biotron is worthy of people capitals or funding by a partner. I don't understand your motive to continually ridicule the result when no one knows the full results.

Cheers